Indee Labs Secures Funding to Develop Unique Gene Therapy Manufacturing Technology in Australia
Indee Labs will receive grant funding of nearly $1M from the Australian Government’s $35 million BioMedTech Horizons program. The project will see Indee Labs make a new generation of medicine, known as gene therapy, accessible to the masses. The impact of gene therapies will be similar to that of antibiotics seen during the last century – it will offer cures for most cancer sufferers with minimal side effects. Kymriah and Yescarta were the first to be approved by the United States Food and Drug Administration last year and there are many hundreds more in development.